Description: Cline Scientific AB (publ) develops cancer diagnostics and regenerative medicine treatments in Sweden. It develops an allogenic stem cell therapy based on induced pluripotent stem (iPS) cells. The company also develops surface nanotechnology for cell-based products and processes to drive projects within life science into the clinical phase. It has collaboration with AstraZeneca to utilize gradient technology. Cline Scientific AB (publ) was founded in 2012 and is based in Mölndal, Sweden.
Home Page: www.clinescientific.com
Argongatan 2C
Mölndal,
431 53
Sweden
Phone:
46 3 13 87 55 55
Officers
| Name | Title |
|---|---|
| Mr. Patrik Sundh | Co-Founder, CEO, Pres & Director |
| Mr. Håkan Bengtsson | Chief Financial Officer |
Exchange: ST
Country: SE
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.1445 |
| Price-to-Sales TTM: | 5.5104 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2 |